Renal response and hematological response rates in patients receiving PVD regimen (n = 61)
| . | Response . | At 3 mo, n (%) . | Best response, n (%) . |
|---|---|---|---|
| Renal response | CR | 18 (29.5) | 25 (41.0) |
| PR | 6 (9.8) | 6 (9.8) | |
| MR | 22 (36.1) | 17 (27.9) | |
| NR | 15 (24.6) | 13 (21.3) | |
| ORR | 46 (75.4) | 48 (78.7) | |
| MRR | 24 (39.3) | 31 (50.8) | |
| Hematological response | sCR | 8 (13.1) | 27 (44.3) |
| CR | 7 (11.5) | 6 (9.8) | |
| VGPR | 24 (39.3) | 14 (23.0) | |
| PR | 14 (23.0) | 9 (14.8) | |
| MR | 5 (8.2) | 2 (3.3) | |
| SD | 1 (1.6) | 1 (1.6) | |
| Missing | 2 (3.3) | 2 (3.3) | |
| ORR | 53 (86.9) | 56 (91.8) | |
| ≥VGPR | 39 (63.9) | 47 (77.0) |
| . | Response . | At 3 mo, n (%) . | Best response, n (%) . |
|---|---|---|---|
| Renal response | CR | 18 (29.5) | 25 (41.0) |
| PR | 6 (9.8) | 6 (9.8) | |
| MR | 22 (36.1) | 17 (27.9) | |
| NR | 15 (24.6) | 13 (21.3) | |
| ORR | 46 (75.4) | 48 (78.7) | |
| MRR | 24 (39.3) | 31 (50.8) | |
| Hematological response | sCR | 8 (13.1) | 27 (44.3) |
| CR | 7 (11.5) | 6 (9.8) | |
| VGPR | 24 (39.3) | 14 (23.0) | |
| PR | 14 (23.0) | 9 (14.8) | |
| MR | 5 (8.2) | 2 (3.3) | |
| SD | 1 (1.6) | 1 (1.6) | |
| Missing | 2 (3.3) | 2 (3.3) | |
| ORR | 53 (86.9) | 56 (91.8) | |
| ≥VGPR | 39 (63.9) | 47 (77.0) |
PR, partial response; MR, minor response; NR, no response; ORR, overall response rate (CR + PR + MR for renal response and sCR + CR + VGPR + PR for hematological response); MRR, major response rate (CR + PR); sCR, stringent complete response.